You sing the praises of Xero, and seem very likely to continue using it, but you recommend we invest in NOV because you're invested in NOV ?? So, whose your hero - Xero or NOV ? Why not switch to Reckon and use NOV and report back ??
I have to agree with JC sentiments - so much hype and overuse of questionable statistics - % increases of modest amounts is very modest. My broker's NOV excuse is "the sentiment in the entire sector is crap" as though thats the market being illogical, and when it comes to its sense, NOV will be OK. I'm sure AfterPay investors who didn't take the money and run wont find much comfort in that fatuous line of argument ! Best case analysis, NOV is several years from real profitability ??
- Forums
- ASX - By Stock
- NOV
- Ann: RKN: Reckon and Novatti - Payment Solutions
Ann: RKN: Reckon and Novatti - Payment Solutions, page-42
Featured News
Add NOV (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
-0.002(5.56%) |
Mkt cap ! $13.81M |
Open | High | Low | Value | Volume |
3.7¢ | 4.1¢ | 3.4¢ | $187.9K | 4.949M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 127555 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 150000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 27555 | 0.034 |
4 | 217935 | 0.033 |
8 | 525120 | 0.032 |
8 | 506731 | 0.031 |
10 | 1286467 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 150000 | 1 |
0.036 | 1300000 | 1 |
0.038 | 100000 | 1 |
0.039 | 400000 | 2 |
0.040 | 2342775 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NOV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online